Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Investments

v3.10.0.1
Cash, Cash Equivalents and Investments
6 Months Ended
Jun. 30, 2018
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Investments Cash, Cash Equivalents and Investments
 
Cash, cash equivalents and investments consisted of the following:
 
 
As of 
 December 31, 
 2017
 
As of 
 June 30, 
 2018
 
(in thousands)
Cash and cash equivalents
 

 
 
Cash
$
146,294

 
$
169,324

Money market funds
353,303

 
75,223

Commercial paper

 
38,442

Corporate debt securities

 
10,007

Total cash and cash equivalents
$
499,597

 
$
292,996

Short-term investments
 

 
 

Commercial paper
$

 
$
111,164

Corporate debt securities
1,250

 
16,627

Total short-term investments
$
1,250

 
$
127,791

Cash, cash equivalents and investments
$
500,847

 
$
420,787


 
Our short-term investments have maturities of twelve months or less and are classified as available-for-sale.

The following table summarizes our available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of June 30, 2018. As of December 31, 2017, the adjusted cost and fair value by significant investment category are the same.
 

 
As of June 30, 2018
 
Adjusted
Cost
 
Unrealized
Losses
 
Fair
Value
 
(in thousands)
Money market funds
$
75,223

 
$

 
$
75,223

Commercial paper
149,606

 

 
149,606

Corporate debt securities
26,642

 
(8
)
 
26,634

Total cash equivalents and marketable securities
$
251,471

 
$
(8
)
 
$
251,463


 
All of our investments have maturities of twelve months or less as of December 31, 2017 and June 30, 2018.
 
We had no securities that had been in a continuous unrealized loss position for greater than 12 months as of December 31, 2017 and June 30, 2018.

Our investment policy requires investments to be investment grade, primarily rated "A1" by Standard & Poor’s or "P1" by Moody’s or better for short-term investments and rated "A" by Standard & Poor’s or "A2" by Moody’s or better for long-term investments, with the objective of minimizing the potential risk of principal loss. In addition, the investment policy limits the amount of credit exposure to any one issuer.
 
The unrealized losses on our available-for-sale securities as of June 30, 2018 were primarily a result of unfavorable changes in interest rates subsequent to the initial purchase of these securities. As of June 30, 2018, we owned nine securities that were in an unrealized loss position. Based on our cash flow needs, we may be required to sell a portion of these securities prior to maturity. However, we expect to recover the full carrying value of these securities. As a result, no portion of the unrealized losses at June 30, 2018 is deemed to be other-than-temporary, and the unrealized losses are not deemed to be credit losses. When evaluating investments for other-than-temporary impairment, we review factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and our intent to sell, or whether it is more likely than not we will be required to sell the investment before recovery of the investment’s amortized cost basis. During the three and six months ended June 30, 2018, we did not recognize any impairment charges. There were no sales of available-for-sale securities during the three and six months ended June 30, 2018.